News,Media Attention
The Golden Hour, Uninterrupted: Peer-Reviewed Research Validates Wireless Monitoring Directly After Birth
2026-04-14
The Golden Hour, Uninterrupted: Peer-Reviewed Research Validates Wireless Monitoring Directly After Birth
New peer-reviewed clinical research conducted at Jeroen Bosch Hospital in ’s-Hertogenbosch, The Netherlands, demonstrates that wireless, non-adhesive neonatal monitoring can reliably capture heart rate and respiratory activity within seconds after birth — without skin preparation and without disturbing skin-to-skin contact during the Golden Hour. Jeroen Bosch Hospital is a large teaching hospital with specialized obstetric and neonatal services and an active focus on clinical research aimed at improving care during the critical transition period immediately after birth. The study, “Wireless monitoring directly after birth in term neonates: A feasibility study,” published in Early Human Development, evaluated the feasibility and ease of use of a wireless belt designed for neonatal cardiorespiratory monitoring immediately after birth.
Protecting the Golden Hour While Enabling Monitoring
The first hour after birth — often referred to as the Golden Hour — is a critical period for physiological transition, bonding, and the initiation of breastfeeding. Continuous monitoring of vital signs is essential during this time, as up to 15% of newborns may require some form of medical support. However, traditional monitoring methods often rely on adhesive electrodes and skin preparation, which can interfere with uninterrupted skin-to-skin contact. This new study demonstrates that wireless monitoring can support clinical assessment while preserving this important early interaction between parent and newborn.
Key Study Findings
The prospective observational study included healthy term infants monitored directly after birth while placed on their mother’s chest. Key outcomes include:
The authors conclude that wireless, non-adhesive monitoring is a feasible solution for use immediately after birth and may help address a long-standing challenge in neonatal care: obtaining rapid and reliable vital sign data without disrupting the Golden Hour.
Supporting Evidence-Based Innovation in Neonatal Care
Rapid and accurate heart rate assessment is a cornerstone of neonatal stabilization guidelines. By enabling near-immediate signal acquisition while maintaining skin-to-skin positioning, the findings suggest that wireless monitoring may help bridge the gap between clinical monitoring needs and family-centered care practices. While the study was conducted in healthy term infants, the authors note that further research may explore broader neonatal populations.
Quote from the primary investigator
“In this study, we were able to obtain heart rate and respiratory signals within seconds after birth, without preparing the skin and without interrupting skin-to-skin contact,” said Marisse Meeus, MD, primary investigator at Jeroen Bosch Hospital. “That combination of rapid signal acquisition and preservation of the Golden Hour is highly relevant for delivery room practice.”
Quote from the CEO
“We are proud to see independent clinical research demonstrating the feasibility of wireless monitoring directly after birth,” said Fabio Bambang Oetomo, CEO of Bambi Medical. “Rapid heart rate is essential in neonatal care. These findings reinforce that monitoring can be both clinically robust and compatible with family-centered practices such as skin-to-skin care.”
About Bambi Medical
Bambi Medical develops gentle, wireless monitoring solutions designed specifically for newborn infants. The company’s mission is to improve neonatal care by combining clinical evidence, innovative technology, and a strong focus on supporting early parent-infant bonding.
Scientific reference: Meeus M, Dingemanse H, Jacobs C, et al. Wireless monitoring directly after birth in term neonates: A feasibility study. Early Human Development. 2026;213:106454.
Note: The device referenced in this publication is CE-marked under the European Medical Device Regulation (EU MDR) for specific indications. This study was an investigator-initiated research project, sponsored and conducted independently by Jeroen Bosch Hospital. Bambi Medical did not sponsor, fund, or direct the design, execution, or analysis of this study. The use described in this study was evaluated by the investigators within a clinical research setting and may not reflect the currently approved intended use in all regions and do not constitute a claim by Bambi Medical regarding approved indications, intended use, or clinical performance beyond the device's current CE-marked scope. Additional studies may be required to support potential future claims or indication expansions. Regulatory status and availability vary by country.
As privacy regulations oblige us to confirm your opt-in, we please ask you to click on the button in the email we've just sent. If you can't find it in your inbox, please check your spam folder.
You also might like:
